Inhibitory effect of quercetin on OVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumours and cultured cells.
We investigated the effect of the flavonoid quercetin (Q) on the proliferation of the ovarian cancer cell line OVCA 433. Growth experiments demonstrated that Q exerted a reversible dose-dependent inhibition of cell proliferation in the range of concentrations between 10 nM and 10 microM. Two other flavonoids tested, rutin and hesperidin, were ineffective in inhibiting cell growth. Cell cycle analysis showed that the growth inhibitory effect of Q was due to a blocking effect in the GO/G1 phase. Using a whole cell assay with (6.7-3H) oestradiol (3H-E2) as tracer we demonstrated that OVCA 433 cells contain type II oestrogen binding sites (type II EBS). Competition analysis showed that Q competed for 3H-E2 binding to type II EBS while both rutin and hesperidin did not. Appreciable amounts of type II EBS were also detected in seven primary ovarian tumours. Our results suggest that Q may regulate ovarian cancer cell growth through a mechanism involving a binding interaction with type II EBS. This mechanism could also be active in vivo since primary ovarian tumours contain type II EBS.
Scambia
G
G
Department of Gynaecology, Catholic University, Rome, Italy.
Ranelletti
F O
FO
Panici
P B
PB
Piantelli
M
M
Bonanno
G
G
De Vincenzo
R
R
Ferrandina
G
G
Rumi
C
C
Larocca
L M
LM
Mancuso
S
S
D002455:Cell Division / Q000187:drug effects; D004958:Estradiol / Q000378:metabolism; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000737:chemistry / Q000473:pathology*; D011794:Quercetin / Q000494:pharmacology*; D011960:Receptors, Estrogen / Q000032:analysis*; D014407:Tumor Cells, Cultured
D011960:Receptors, Estrogen; D004958:Estradiol; D011794:Quercetin